Cargando…
The landscape of m6A regulators in esophageal cancer: molecular characteristics, immuno-oncology features, and clinical relevance
BACKGROUND: Squamous cell carcinoma (SCC) and adenocarcinoma (AC) are the two main pathological types of esophageal cancer (EC), which differ in molecular features, genetic variation, and treatment sensitivity. However, as a key process in tumorigenesis and development, the role of N6-methyladenosin...
Autores principales: | Li, Zhe, Zheng, Chunyan, Huang, Liquan, Yin, Xiaoyang, Wang, Zhongtang, Liu, Chengxin, Li, Baosheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843396/ https://www.ncbi.nlm.nih.gov/pubmed/36660671 http://dx.doi.org/10.21037/atm-22-5895 |
Ejemplares similares
-
The landscape of m(6)A regulators in small cell lung cancer: molecular characteristics, immuno-oncology features, and clinical relevance
por: Zhang, Chaoqi, et al.
Publicado: (2021) -
The landscape of UBE2S in hepatocellular carcinoma: Prognostic significance, immuno-oncology feature and drug response
por: Qiu, Lipeng, et al.
Publicado: (2022) -
Immune landscape and biomarkers for immuno-oncology in colorectal cancers
por: Bae, Jeong Mo, et al.
Publicado: (2020) -
Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017) -
Insights into immuno-oncology drug development landscape with focus on bone metastasis
por: Kähkönen, Tiina E., et al.
Publicado: (2023)